top of page

"BMB has its optics focused on challenging the current standard-of-care implantable metal fixators for fracture treatments. As no competitive technology exists on the market, BMB’s Bonevolent™ platform will be the first mover by providing patient-personalized composite-based fixators that enhances the patient’s ability to recover, independent if it is for human or animal wellbeing."
Michael Malkoch
Founder

The Markets
The Markets


Why Invest
Why Invest

Why Invest
bottom of page